LncRNA Information | ||||||
---|---|---|---|---|---|---|
ID | EL1057 | Name | PCAT7 | Aliases | PCAN-R2 | |
Species | Homo sapiens | Chromosome | 9 | Start site | 94555069 | |
End site | 94568127 | Chain | plus | Exon NO. | 3 | |
Assembly | Ensembl Release 89 | Class | retained intron | NCBI accession | NR_121566, NR_121567, NR_121569, NR_121568 | |
Ensembl | ENSG00000231806 | Sequence |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
prostate cancer | microarray, RNA-seq, qPCR, Northern bolt, knockdown etc. | prostate cancer tissue, cell lines (LNCaP, CWR22Rv1, PC3 etc.) | up-regulated | N/A | Both lncRNA showed positive correlation between gene expression and SCNA. The criteria of increasing expression from normal to primary to metastatic prostate cancer aimed to uncover lncRNA that may be important therapeutic targets for both primary and metastatic cancers. | 23728290 | Lnc2Cancer | ||